The role of obeticholic acid

In the medical field, primary cholangitis, as a unique autoimmune disease, has always attracted much attention. The main characteristic of this disease is that it damages the bile ducts in the liver that carry bile to the intestines, thereby disrupting the natural balance of bile flow. When bile cannot be excreted normally in the liver, it will gradually accumulate, causing continuous damage to the liver. Against this background, obeticholic acid, as an innovative drug, brings new hope to patients with primary cholangitis.

As a farnesoidX receptor agonist, obeticholic acid plays a vital role in the liver. It regulates bile production and excretion by activating farnesoid X receptors in the body, an important protein switch. Specifically, obeticholic acid reduces the amount of bile the body produces, reducing the burden on the liver. At the same time, it can also promote the discharge of bile and ensure that bile will not stay in the liver for a long time, further protecting the health of the liver. This dual mechanism of action makes obeticholic acid an effective drug for the treatment of primary cholangitis.

It is worth mentioning that obeticholic acid not only has significant therapeutic effects, but also has relatively minor side effects, providing patients with a safer and more reliable treatment option.

It is understood that obeticholic acid has not yet obtained marketing approval in the Chinese market. Therefore, if patients want to use this drug, they need to purchase and use it through overseas channels. In overseas markets, patients can find both the original brand of obeticholic acid and affordable generic drugs to choose from. When choosing to purchase medicines, patients must be cautious, be sure to purchase through formal channels, and carefully identify the authenticity of the medicines to ensure the safety of the medicines. Therefore, patients can seek consultation and assistance from qualified and reputable overseas medical institutions.